
Chemicals & Petrochemicals
Valuation | |
|---|---|
| Market Cap | 22.4 kCr |
| Price/Earnings (Trailing) | 42.15 |
| Price/Sales (Trailing) | 2.81 |
| EV/EBITDA | 24.33 |
| Price/Free Cashflow | -48.79 |
| MarketCap/EBT | 30.62 |
| Enterprise Value | 23.53 kCr |
Fundamentals | |
|---|---|
Growth & Returns | |
|---|---|
| Price Change 1W | 5.1% |
| Price Change 1M | -5.2% |
| Price Change 6M | -9.7% |
| Price Change 1Y | -27.7% |
| 3Y Cumulative Return | -4.4% |
| 5Y Cumulative Return | 11.1% |
| 7Y Cumulative Return | 32.6% |
| 10Y Cumulative Return | 38.3% |
| Revenue (TTM) |
| 7.96 kCr |
| Rev. Growth (Yr) | -6.4% |
| Earnings (TTM) | 531.63 Cr |
| Earnings Growth (Yr) | -38.9% |
Profitability | |
|---|---|
| Operating Margin | 9% |
| EBT Margin | 9% |
| Return on Equity | 9.58% |
| Return on Assets | 6.74% |
| Free Cashflow Yield | -2.05% |
Cash Flow & Liquidity |
|---|
| Cash Flow from Investing (TTM) | -1.49 kCr |
| Cash Flow from Operations (TTM) | 624.7 Cr |
| Cash Flow from Financing (TTM) | 806.16 Cr |
| Cash & Equivalents | 22.5 Cr |
| Free Cash Flow (TTM) | -497.37 Cr |
| Free Cash Flow/Share (TTM) | -36.47 |
Balance Sheet | |
|---|---|
| Total Assets | 7.88 kCr |
| Total Liabilities | 2.33 kCr |
| Shareholder Equity | 5.55 kCr |
| Current Assets | 2.8 kCr |
| Current Liabilities | 887.36 Cr |
| Net PPE | 2.51 kCr |
| Inventory | 903.77 Cr |
| Goodwill | 2.66 Cr |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.15 |
| Debt/Equity | 0.21 |
| Interest Coverage | 22.21 |
| Interest/Cashflow Ops | 21.91 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 7.5 |
| Dividend Yield | 0.46% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.00% |
Balance Sheet: Strong Balance Sheet.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Size: Market Cap wise it is among the top 20% companies of india.
Growth: Declining Revenues! Trailing 12m revenue has fallen by -5.3% in past one year. In past three years, revenues have changed by 3.9%.
Insider Trading: Significant insider selling noticed recently.
Smart Money: Smart money is losing interest in the stock.
Past Returns: Underperforming stock! In past three years, the stock has provided -4.4% return compared to 11.4% by NIFTY 50.
Balance Sheet: Strong Balance Sheet.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Size: Market Cap wise it is among the top 20% companies of india.
Growth: Declining Revenues! Trailing 12m revenue has fallen by -5.3% in past one year. In past three years, revenues have changed by 3.9%.
Insider Trading: Significant insider selling noticed recently.
Smart Money: Smart money is losing interest in the stock.
Past Returns: Underperforming stock! In past three years, the stock has provided -4.4% return compared to 11.4% by NIFTY 50.
Investor Care | |
|---|---|
| Dividend Yield | 0.46% |
| Dividend/Share (TTM) | 7.5 |
| Shares Dilution (1Y) | 0.00% |
| Earnings/Share (TTM) | 38.97 |
Financial Health | |
|---|---|
| Current Ratio | 3.16 |
| Debt/Equity | 0.21 |
Technical Indicators | |
|---|---|
| RSI (14d) | 42.92 |
| RSI (5d) | 44.49 |
| RSI (21d) | 31.32 |
| MACD Signal | Sell |
| Stochastic Oscillator Signal | Hold |
| SharesGuru Signal | Buy |
| RSI Signal | Hold |
| RSI5 Signal | Hold |
| RSI21 Signal | Hold |
| SMA 5 Signal | Buy |
| SMA 10 Signal |
Updated May 5, 2025
Despite the recent increase, Deepak Nitrite has underperformed this year with a -20.23% return.
Deepak Chemtex has declined by 13.02% over the last three months, reflecting a challenging market environment.
Foreign Institutional Investor holdings in Deepak Nitrite have decreased to 6.59%, indicating reduced foreign interest.
Summary of Deepak Nitrite's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
In the earnings conference call for Q2 & H1 FY26 held on November 14, 2025, management provided an optimistic outlook for Deepak Nitrite. The consolidated revenue increased to INR 1,922 crore, showcasing a 5% quarter-on-quarter growth and a focus on improving profitability, with EBITDA reported at INR 224 crore.
Key forward-looking points highlighted by management include:
Phenolics Performance: The Phenolics segment is expected to continue thriving, driven by record production of Isopropyl Alcohol and better profit margins due to favorable feedstock pricing.
Advanced Intermediates (AI) Expectations: Despite tariff pressures and underpriced imports, management anticipates improved performance from AI due to a recovery in volumes from agrochemical-linked intermediates, particularly from Europe, and enhanced contributions from debottlenecked capacities expected to come online in Q4 FY26.
New Asset Developments: The commencement of a hydrogenation asset at Deepak Chem Tech, with an investment of INR 118 crore, and a new R&D center at Savli, built at INR 100 crore, are aimed at fostering innovation and product diversification to enhance operational capabilities.
Sustainability Initiatives: Management aims to transition towards 60% renewable energy consumption, potentially reaching 70% with favorable regulatory conditions. This aligns with their commitment to sustainability and operational excellence.
Capacity Expansion: The company is on track for significant capacity expansions in upstream (Nitric Acid) and downstream products (MIBK, MIBC), projected to be operational by early 2026, which is expected to bolster competitiveness and profitability.
Long-term Investment Plans: There is a strategic plan for a mega integrated polycarbonate project that aligns with the 'Atmanirbhar Bharat' initiative, which is expected to enhance backward and forward integration for sustained growth.
In summary, management's outlook reflects strong confidence in leveraging operational improvements, new initiatives, and strategic expansions to drive future growth despite current market challenges.
Understand Deepak Nitrite ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| Deepak Chimanlal Mehta | 16.56% |
| Life Insurance Corporation Of India | 9.47% |
| Stiffen Credits And Capital Pvt Ltd | 6.19% |
| Checkpoint Credits And Capital Pvt Ltd | 5.28% |
| Stepup Credits And Capital Pvt Ltd | 5.08% |
| Stigma Credits And Capital P Ltd | 4.54% |
| Deepak Novochem Technologies Limited |
Detailed comparison of Deepak Nitrite against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Comprehensive comparison against sector averages
DEEPAKNTR metrics compared to Chemicals
| Category | DEEPAKNTR | Chemicals |
|---|---|---|
| PE | 40.59 | 43.75 |
| PS | 2.71 | 4.07 |
| Growth | -5.3 % | 5.3 % |
Deepak Nitrite is a Specialty Chemicals company based in India, with the stock ticker DEEPAKNTR. The company has a market capitalization of Rs. 26,978.5 Crores.
It specializes in the manufacturing, trading, and sale of chemical intermediates both domestically and internationally. Deepak Nitrite operates through two segments: Advanced Intermediates and Phenolics.
The product portfolio includes a wide range of chemicals such as:
These products cater to various industries including colourants, dyes, rubber, paper, agrochemicals, pharmaceuticals, personal care, water treatment, glass, explosives, and textiles.
Furthermore, Deepak Nitrite provides essential chemicals like:
These are applied in areas such as laminate and plywood, automotive, construction, pharmaceuticals, adhesives, sanitizers, rubber, chemicals, and paints.
The company also offers various specialty products and services, including project engineering, procurement, construction, commissioning, management, and consultancy services.
Incorporated in 1970 and headquartered in Vadodara, India, Deepak Nitrite has demonstrated strong performance with a trailing 12 months revenue of Rs. 8,308.7 Crores. It also distributes dividends to its investors with a yield of 0.34% per year, having returned Rs. 7.5 dividend per share in the last 12 months. The company has achieved 29% revenue growth over the past three years.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
| Buy |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Sell |
| SMA 100 Signal | Sell |
DEEPAKNTR vs Chemicals (2021 - 2026)
Deepak Nitrite's stock is currently trading 2.97% higher at Rs 1,989.35, indicating a positive movement.
General • 29 Jan 2026 Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 |
General • 19 Jan 2026 Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 |
General • 09 Jan 2026 Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 |
General • 07 Jan 2026 Disclosure under Regulation 30 of SEBI (LODR), Regulations, 2015 |
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 • 05 Jan 2026 Certificate under Regulation 74(5) of SEBI (DP) Regulation |
General • 19 Dec 2025 Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 |
This information is AI-generated and may contain inaccuracies. Please verify from multiple sources.
Here are the major questions and their answers from the Q&A section of the earnings transcript:
Question 1: "In the Advanced Intermediates business, we've seen some volume erosion from peak levels. How much has fallen from those peak volumes?"
Answer: "In Q2, we basically sent close to zero volumes due to an intense inventory destocking over several quarters. Customers were focused on releasing their own inventory, which severely impacted our intermediates. Overall, these products were noticeably absent from our Q2 results."
Question 2: "What do you anticipate for volume recovery in the second half based on customer interactions?"
Answer: "We are cautiously optimistic. Most customers await clarity around U.S. tariffs and crop conditions. We expect volumes to improve beyond the near-zero levels of Q2, with a noticeable uptick beginning this month or next. There are ongoing discussions for volumes across various geographies."
Question 3: "How do our ammonia contracts stand, and how are we addressing storage and transportation costs?"
Answer: "We have diversified sourcing for ammonia, importing as needed and utilizing domestic suppliers. Historically, our storage was minimal, but we've recently doubled capacity, allowing for approximately 15 days of consumption. This will help minimize costs moving forward."
Question 4: "Regarding the capacities for the WNA and CNA plants, could you share the operationalized capacities?"
Answer: "We will produce roughly between 250-270 tons per day for both WNA and concentrated acid. Demand dynamics will influence whether this output covers captive consumption or allows for market sales."
Question 5: "What will be the Y-o-Y growth for phenol, particularly in Q2?"
Answer: "Growth in Q2 was modest at about 2-3%. Seasonal factors affected production, so we expect more efficient operations in H2. Previous growth targets have been surpassed, but challenges in sales also impacted these results."
Question 6: "Can you provide a revenue and profitability outlook for the next quarter or fiscal year?"
Answer: "We remain cautiously optimistic about H2, expecting better performance driven by improved market sentiment and the commissioning of investments in Deepak Chem Tech."
Question 7: "How does the new R&D center enhance flexibility in capital investments amidst market volatilities?"
Answer: "The R&D facility allows us to develop new chemistries and optimize existing processes quickly. It helps us to adapt rapidly to market changes, reducing the risks associated with substantial long-term CAPEX."
These summaries capture the essence of each discussion point while conforming to the character limit.
| 3.41% |
| Kotak Midcap Fund | 3.18% |
| Skyrose Finvest Pvt Ltd | 2.81% |
| Franklin India Small Cap Fund | 2.63% |
| Pranawa Leafin Pvt Ltd | 1.69% |
| Forex Leafin Pvt Ltd | 1.59% |
| Icici Prudential Multicap Fund | 1.09% |
| Storewell Credits And Capital Private Ltd | 0.65% |
| Sundown Finvest Pvt Ltd | 0.61% |
| Ila Deepak Mehta | 0.44% |
| Hardik Leafin Pvt Ltd | 0.25% |
| Maulik Deepak Mehta | 0.1% |
| Prahaan Maulik Mehta | 0.03% |
| Aadya Meghav Mehta | 0.03% |
Distribution across major stakeholders
Distribution across major institutional holders
| +12.40% |
| 28.75 |
| 4.72 |
| - |
| - |
| ATUL | Atul | 18.29 kCr | 6.22 kCr | +1.20% | -1.90% | 30.78 | 2.94 | - | - |
| VINATIORGA | Vinati Organics | 15.83 kCr | 2.3 kCr | -3.90% | -7.00% | 36.31 | 6.89 | - | - |
| AARTIIND | Aarti Industries | 13.49 kCr | 7.57 kCr | -0.50% | -15.10% | 69.26 | 1.78 | - | - |
| ALKYLAMINE | Alkyl Amines Chemicals | 8.03 kCr | 1.58 kCr | -1.60% | -7.70% | 44.08 | 5.07 | - | - |
| BALAMINES | Balaji Amines | 3.62 kCr | 1.41 kCr | -0.40% | -33.60% | 25.24 | 2.56 | - | - |
| -0.1% |
| 1,759 |
| 1,760 |
| 1,924 |
| 1,789 |
| 1,789 |
| 1,911 |
| Profit Before exceptional items and Tax | 5.2% | 163 | 155 | 279 | 135 | 264 | 275 |
| Exceptional items before tax | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Total profit before tax | 5.2% | 163 | 155 | 279 | 135 | 264 | 275 |
| Current tax | 0% | 42 | 42 | 46 | 37 | 71 | 74 |
| Deferred tax | 450% | 2.47 | 0.58 | 30 | 0.04 | -1.18 | -2.03 |
| Total tax | 4.9% | 44 | 42 | 76 | 37 | 70 | 72 |
| Total profit (loss) for period | 6.3% | 119 | 112 | 202 | 98 | 194 | 203 |
| Other comp. income net of taxes | -118.6% | -2.65 | -0.67 | -1.6 | -0.71 | -0.56 | -0.44 |
| Total Comprehensive Income | 3.6% | 116 | 112 | 201 | 97 | 194 | 202 |
| Earnings Per Share, Basic | 6.6% | 8.71 | 8.23 | 14.84 | 7.19 | 14.24 | 14.85 |
| Earnings Per Share, Diluted | 6.6% | 8.71 | 8.23 | 14.84 | 7.19 | 14.24 | 14.85 |
| 10% |
| 275 |
| 250 |
| 230 |
| 197 |
| 181 |
| 175 |
| Finance costs | 155% | 3.78 | 2.09 | 1.57 | 1.6 | 4.12 | 20 |
| Depreciation and Amortization | 15.1% | 100 | 87 | 76 | 73 | 67 | 78 |
| Other expenses | 4.6% | 552 | 528 | 548 | 448 | 321 | 370 |
| Total Expenses | -1.4% | 2,338 | 2,370 | 2,525 | 1,940 | 1,344 | 1,531 |
| Profit Before exceptional items and Tax | -29.4% | 338 | 478 | 610 | 642 | 479 | 706 |
| Exceptional items before tax | -101.3% | 0 | 80 | 0 | 0 | 0 | 0 |
| Total profit before tax | -39.5% | 338 | 558 | 610 | 642 | 479 | 706 |
| Current tax | -52.7% | 62 | 130 | 134 | 153 | 123 | 192 |
| Deferred tax | 62.5% | -1.27 | -5.06 | 6.73 | 3.28 | 0.67 | -30.09 |
| Total tax | -51.6% | 61 | 125 | 140 | 156 | 124 | 162 |
| Total profit (loss) for period | -36.3% | 276 | 433 | 469 | 486 | 355 | 544 |
| Other comp. income net of taxes | -20.3% | -2.2 | -1.66 | -4.85 | 0.06 | -1.3 | -3.66 |
| Total Comprehensive Income | -36.7% | 274 | 432 | 465 | 486 | 353 | 540 |
| Earnings Per Share, Basic | -37.4% | 20.27 | 31.78 | 34.41 | 35.65 | 26.01 | 39.89 |
| Earnings Per Share, Diluted | -37.4% | 20.27 | 31.78 | 34.41 | 35.65 | 26.01 | 39.89 |
| Debt equity ratio | - | - | - | - | - | - | 014 |
| Debt service coverage ratio | - | - | - | - | - | - | 0.0603 |
| Interest service coverage ratio | - | - | - | - | - | - | 0.4191 |
| 4% |
| 931 |
| 895 |
| 882 |
| 833 |
| 750 |
| 726 |
| Capital work-in-progress | -11.2% | 151 | 170 | 105 | 126 | 114 | 77 |
| Non-current investments | 7.6% | 1,382 | 1,284 | 1,040 | 855 | 799 | 688 |
| Loans, non-current | -245.7% | 0.49 | 1.35 | 1.69 | 1.54 | 0.84 | 0.7 |
| Total non-current financial assets | 7.7% | 1,393 | 1,293 | 1,046 | 860 | 806 | 694 |
| Total non-current assets | 5.3% | 2,497 | 2,372 | 2,047 | 1,831 | 1,693 | 1,523 |
| Total assets | 0.1% | 3,620 | 3,617 | 3,503 | 3,371 | 3,172 | 3,050 |
| Total non-current financial liabilities | 0% | 29 | 29 | 30 | 30 | 2.3 | 10 |
| Provisions, non-current | 12.9% | 36 | 32 | 31 | 29 | 29 | 26 |
| Total non-current liabilities | 9% | 122 | 112 | 110 | 108 | 83 | 93 |
| Borrowings, current | -77.6% | 5.04 | 19 | 19 | 0 | 5.67 | 0 |
| Total current financial liabilities | -15.8% | 295 | 350 | 306 | 271 | 291 | 306 |
| Provisions, current | -6.2% | 16 | 17 | 13 | 17 | 13 | 14 |
| Current tax liabilities | 0% | 1.98 | 1.98 | 5.02 | 7.39 | 0 | 0 |
| Total current liabilities | -12.4% | 332 | 379 | 337 | 308 | 323 | 331 |
| Total liabilities | -7.3% | 455 | 491 | 446 | 416 | 407 | 425 |
| Equity share capital | 0% | 27 | 27 | 27 | 27 | 27 | 27 |
| Total equity | 1.2% | 3,165 | 3,126 | 3,057 | 2,955 | 2,765 | 2,625 |
| Total equity and liabilities | 0.1% | 3,620 | 3,617 | 3,503 | 3,371 | 3,172 | 3,050 |
| -48.4% |
| 64 |
| 123 |
| 139 |
| 152 |
| - |
| - |
| Net Cashflows From Operating Activities | -39.3% | 254 | 418 | 310 | 228 | - | - |
| Cashflows used in obtaining control of subsidiaries | 157.8% | 429 | 167 | 216 | 196 | - | - |
| Proceeds from sales of PPE | 627.3% | 17 | 3.2 | 0.86 | 118 | - | - |
| Purchase of property, plant and equipment | 1% | 210 | 208 | 125 | 104 | - | - |
| Purchase of intangible assets | -209.4% | 0.65 | 1.32 | 1.15 | 0.31 | - | - |
| Cash receipts from repayment of advances and loans made to other parties | 10.8% | 175 | 158 | 0 | 0 | - | - |
| Dividends received | 29.3% | 98 | 76 | 62 | 39 | - | - |
| Interest received | -16.4% | 7.77 | 9.1 | 0.53 | 0.55 | - | - |
| Net Cashflows From Investing Activities | -112.2% | -332.53 | -156.16 | -188.47 | -159.13 | - | - |
| Proceeds from borrowings | - | 19 | 0 | -13.99 | 14 | - | - |
| Payments of lease liabilities | -88.2% | 1.16 | 2.36 | 0 | 0 | - | - |
| Dividends paid | 0% | 102 | 102 | 95 | 75 | - | - |
| Interest paid | 1843.7% | 3.79 | 0.84 | 0.32 | 1.61 | - | - |
| Other inflows (outflows) of cash | 2% | 0.01 | -0.01 | -0.01 | 0 | - | - |
| Net Cashflows from Financing Activities | 16.1% | -88.37 | -105.5 | -112.83 | -64.36 | - | - |
| Net change in cash and cash eq. | -207.6% | -166.82 | 157 | 8.71 | 4.38 | - | - |
General • 08 Dec 2025 Report on Special Window for re-lodgement of transfer requests of physical shares for the month of November, 2025 |
Analysis of Deepak Nitrite's financial performance, highlighting revenue trends, growth patterns, and key metrics through quarterly analysis.
Last Updated: Sep 30, 2025
| Description | Share | Value |
|---|---|---|
| Phenolics | 69.4% | 1.3 kCr |
| Advanced Intermediates | 30.6% | 587.8 Cr |
| Total | 1.9 kCr |